Every year more Novartis associates in Slovenia volunteer in local community
- Community Partnership Day commemorates the merger of two companies to form Novartis in 1996
- More than 180 Sandoz and Novartis associates in Slovenia participated in volunteer events today in their communities, more than 14,500 Novartis associates worldwide
- Novartis event emphasizes strong commitment to Corporate Citizenship. The goal is to support projects in local communities, social institutions and non-profit organizations which are in accord with Novartis’ realization of its Corporate Citizenship.
Today, Lek, a Sandoz company, held its fifth annual Community Partnership Day. They joined thousands of Novartis associates worldwide who took part in Community Partnership Day by engaging in volunteer activities to benefit people in their local communities. This year marks Novartis 13th Community Partnership Day, commemorating the 1996 creation of Novartis as a global leader in healthcare solutions. About 10,500 associates worldwide joined in the event in 2008, engaging in volunteer work for a wide range of charitable causes.
“Community Partnership Day is a day when associates who wish to participate can take some time which they would otherwise spend at their jobs to visit with and help individuals and various organizations in the communities where they work. Every year that Lek holds Community Partnership Day, we can see that a lot of people who need help feel that the time and effort spent by our volunteers is at least as valuable as funding. Therefore this year again we were very happy to join and to help all the people who we visited,” said Marjan Novak, member of the Lek Board of Management.
This year, more than 180 Lek associates together with associates from Novartis Pharma in Slovenia held various events. Warm meals were cooked for Ljubljana’s homeless and served to them in the afternoon at the Parish Caritas in Štepanja vas, at the homeless people’s shelter on Poljanska street and at the Franciscan church. They spent a day with clients from the Barka Association in Zbilje and cooked lunch and planted flowers in the garden with them. They helped through painting and spring cleaning at the Crisis Center for children and youth in Ljubljana Bezigrad area. They visited the Home for the Elderly in Prevalje, the Home for the Elderly in Mengeš and the Vič-Rudnik Home for the Elderly in Ljubljana, and put on a special day for them including an entertaining social program. Children from the Hans Christian Andersen Daycare Center were treated to a fairy-tale day. Associates from all Lek sites around Slovenia gave blood, some visited the clients of the Korak Trauma Rehabilitation Institute where they landscaped the surroundings and helped in some other activities, as well. At the Billingual Primary School II Lendava they participated in workshops around the World Earth Day, where children spoke about nature, its beauty and value and learned how to preserve it.
This year marks Novartis’ 13th Community Partnership Day, and in this time the initiative has become an important part of the company’s Corporate Citizenship. It has also become one of the most important parts of Lek’s Corporate Citizenship, since it encourages associates to volunteer their time and effort to help make other people’s lives better. This enriches both the volunteers and everyone for whom the help is intended.
- More than 3,800 associates across Switzerland are expected to participate in 215 volunteer projects. In the Basel area, associates are serving in nearly 200 projects, such as taking disabled children to an amusement park and cooking at a battered women’s shelter and an orphanage. In Nyon, associates are creating a puppet theater for autistic children, donating blood to the regional Red Cross, and assisting young people facing difficulties. Associates in Cham will be supporting activities at a kindergarten, taking a trip with retirees and doing forestry work.
- In China, more than 1,100 associates are participating in weeklong activities. Beijing associates will train elementary school students in emergency rescue skills. Along with giving blood and donating clothing, Suzhou associates are warning people against the danger of consuming expired medication. Associates also organized events to raise interest in chemistry among school children.
- Across Germany, 750 associates are “giving back” this week. Novartis volunteers are involved in more than twenty projects, including outings with disabled children and seniors, a management workshop at a student café, and creation of a playground area for a daycare center and an elementary school. Close to 400 associates in Marburg are organizing a sports fair at a boarding school for disabled children, fixing kennels at an animal shelter, painting walls in a children’s hospital, and planting a “Novartis forest” to make up for the damage caused by Hurricane Kyrill in 2007. Associates in Grosswallstadt will offer storytelling at a school for disabled children and a school for the blind and will create a new hallway designed to serve visually impaired children.
- More than 300 associates in Spain are cleaning up a dog shelter and a nature park, donating blood, entertaining at a children’s hospital, and donating clothes to support a local charity.
- In Australia, associates will plant trees in a local national park and carry out renovations for a local community center, including tidying, planting gardens and painting.
- Consumer Health associates in Canada will again partner with Community Living Mississauga, a local not-for-profit organization that provides support to individuals with disabilities. Associates will help through painting, spring cleaning, gardening, arts and crafts.
Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for active pharmaceutical ingredients and medicines, as a competence center for the development of vertically integrated products, as a Sandoz competence center in the field of development and manufacturing of biosimilar products and as a supply center for the markets of CEE, SEE and CIS, sales Slovenia and sales services for Sandoz global markets. For further information please visit http://www.lek.si/eng/
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of approximately 1000 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany) and Eon Labs (US). In 2008, Sandoz employed around 23,000 people worldwide and posted sales of USD 7.6 billion. For further information please visit www.sandoz.com
Novartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2008, the Group’s continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 96,700 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For further information contact:
Katarina Klemenc Dinjaški
Lek Pharmaceuticals d.d.
Phone: + 386 1 580 22 43
Fax: + 386 1 580 24 32